Life Spine Announces 27% Revenue Growth and 79% EBITDA Growth in the First Half of 2019 Over the Same Period In 2018
July 26, 2019
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that they achieved 27% revenue growth and 79% EBITDA growth in the first half of 2019 over the same period in 2018.
“I am very pleased that we delivered another period of significant revenue and EBITDA growth. Our research and development team has been executing at a high level delivering innovative technologies focused around a Micro Invasive approach,” said Omar Faruqi, Chief Financial Officer for Life Spine. “Our continued growth is a testament of the market’s appetite for devices that are designed to reduce surgical time, accelerate patient recovery and reduce costs to the healthcare system.”
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com.